I am a nanoparticle formulation expert with over a decade of experience developing cutting-edge lipid nanomedicines for cancer and cardiovascular diseases. Based in Austin, Texas, I hold a Ph.D. in Biotechnology and specialize in nanoparticle synthesis, formulation, optimization, and characterization.My core expertise is lipid nanoparticles, focusing on formulation, synthesis, and drug delivery systems, particularly for small molecules and RNA-based therapies. I also have extensive experience working with micelle-based systems and lipopeptide self-assembly nanoparticles, and I hold 2+ patents awarded or filed in these areas.As the Principal Investigator for the SBIR Innovative Concept Award Program, I am leading efforts to advance the Targeted Delivery of Ferroptosis Inducers for treating Adrenocortical Carcinoma.I bring advanced chemical synthesis expertise, including modifying small molecule payloads through custom synthesis to enhance loading efficiency for challenging molecules. I am also highly skilled in downstream processing techniques such as tangential flow filtration, ensuring the preparation of final formulations for animal studies and scale-up. My knowledge extends to advanced characterization techniques, including dynamic light scattering (DLS) for particle size analysis, zeta potential for surface charge, and cryo-electron microscopy (Cryo-EM) for structural insights. Additionally, I am proficient in High-Performance Liquid Chromatography (HPLC) and Fast Protein Liquid Chromatography (FPLC). I possess in-depth expertise in stability testing under various conditions (e.g., temperature, pH, and light exposure) and improving nanoparticle stability and shelf life. Furthermore, I have extensive experience conducting pharmacokinetic (PK) and pharmacodynamic (PD) studies to evaluate the efficacy and safety of lipid nanoparticle-based therapies.I excel in leading teams, driving innovation under pressure, and maximizing efficiency with limited resources. My proven problem-solving, collaboration, and innovation track record is reflected in my ability to generate relevant intellectual property in nanoparticle technologies.